Want to see EHC full AI Analyst Report?
EHC Stock Chart & Stats
$106.39
$0.72(0.79%)
At close: 4:00 PM EST
$106.39
$0.72(0.79%)
Day’s Range― - ―
52-Week Range$92.77 - $127.99
Previous CloseN/A
Volume95.02K
Average Volume (3M)1.07M
Market Cap
$11.13B
Enterprise Value$13.17K
Total Cash (Recent Filing)$200.50M
Total Debt (Recent Filing)$2.79B
Price to Earnings (P/E)18.5
Beta0.55
Next Earnings
Aug 05, 2026EPS Estimate
1.48Next Dividend Ex-DateN/A
Dividend Yield0.65%
Share Statistics
EPS (TTM)6.08
Shares Outstanding99,199,080
10 Day Avg. Volume1,054,324
30 Day Avg. Volume1,067,324
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)4.37
Price to Sales (P/S)1.80
P/FCF Ratio24.29
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$136.25Price Target Upside28.07% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)6.01
Revenue Forecast (FY)$6.42B
Bulls Say, Bears Say
Bulls Say
Revenue & EBITDA GrowthSustained top-line and EBITDA expansion, coupled with an upward revision to full-year 2026 guidance, indicates durable demand for post-acute services and ongoing operating leverage. This strengthens predictable cash flow generation and supports reinvestment and debt service over the medium term.
Improved Leverage & High ROEMaterial de-risking of the capital structure and persistent high ROE reflect efficient capital deployment and greater financial flexibility. Lower leverage reduces refinancing risk and supports continued investment in growth initiatives, buybacks, and dividends across the 2–6 month horizon.
Development Pipeline & Capacity ExpansionA sizable, staged expansion pipeline and targeted bed adds address strong demand and high-occupancy markets. New and small-format hospitals expand market presence, provide incremental revenue capacity, and create multi-year growth optionality tied to structural demand for post-acute care.
Bears Say
Weakened Free Cash Flow ConversionA sharp TTM decline in free cash flow conversion versus net income signals pressure from higher CapEx, working capital, or timing items. This undermines cash available for discretionary uses and increases sensitivity to funding needs despite healthy operating cash flow trends.
Medicare Advantage & Regulatory RiskVariability in Medicare Advantage utilization and ongoing regulatory implementations (TEAM, RCD expansion, CMS rule activity) create durable reimbursement and admission uncertainty. These factors can persist for months, complicating volume predictability and revenue per discharge.
Capacity Constraints In High-Demand MarketsSignificant occupancy saturation in a subset of hospitals limits same-store discharge upside until bed additions or small-format sites come online. Capacity bottlenecks can structurally cap near-term organic growth and require capital deployment to convert demand into realized revenue.
Encompass Health News
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $92.77 and its highest was $127.99 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $11.13B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Aug 05, 2026 which is in 16 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Apr 30, 2026. The company reported $1.6 earnings per share for the quarter, beating the consensus estimate of $1.494 by $0.106.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Quarterly dividend of $0.19 which represents an annual dividend yield of 0.65%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.48.
How many shares outstanding does Encompass Health have?
Encompass Health has 99,199,080 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.6 in its last earnings report, beating expectations of $1.494. Following the earnings report the stock price went up 7.479%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Encompass Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$136.25 (28.07% Upside)
$136.25 (28.07% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Decreased
By 352.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 11.1%
Last 30 Days ▲ 11.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.40%
12-Months-Change
Fundamentals
Return on Equity
25.35%
Trailing 12-Months
Asset Growth
10.12%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
EHC Stock 12 Month Forecast
Average Price Target
$136.25
▲(28.07% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―
Ownership Overview
1.20% Insiders
31.56% Mutual Funds
1.49% Other Institutional Investors
42.56% Public Companies and
Individual Investors